Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 6035-6044

  Roy, Sugata ^a   Guler, Reto ^b,c   Parihar, Suraj P ^b,c   Schmeier, Sebastian ^d   Kaczkowski, Bogumil ^a   Nishimura, Hajime ^a   Shin, Jay W ^a   Negishi, Yutaka ^a   Ozturk, Mumin ^b,c   Hurdayal, Ramona ^b,c   Kubosaki, Atsutaka ^a   Kimura, Yasumasa ^a   De Hoon, Michiel J L ^a   Hayashizaki, Yoshihide ^a   Brombacher, Frank ^b,c   Suzuki, Harukazu ^a  

^a RIKEN   (Japan)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12P40; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PROTEIN BATF2; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BATF2 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW DERIVED MACROPHAGE; CCL5 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; GENE CONTROL; GENE INDUCTION; GENE SILENCING; IL12B GENE; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOS2 GENE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TNF GENE; ANIMAL; CLUSTER ANALYSIS; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MYCOBACTERIUM;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; TUMOR NECROSIS FACTORS;

EID: 84931415171     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402521     Document Type: Article

References (55)

1. Gonzalez-Juarrero, M., T. S. Shim, A. Kipnis, A. P. Junqueira-Kipnis, and I. M. Orme. 2003. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171: 3128-3135.
2. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
3. Martinez, F. O., and S. Gordon. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6: 13.
4. Herbert, D. R., C. Hölscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
5. Odegaard, J. I., R. R. Ricardo-Gonzalez, M. H. Goforth, C. R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A. W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447: 1116-1120.
6. Nguyen, K. D., Y. Qiu, X. Cui, Y. P. Goh, J. Mwangi, T. David, L. Mukundan, F. Brombacher, R. M. Locksley, and A. Chawla. 2011. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480: 104-108.
7. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
8. Pace, J. L., S. W. Russell, R. D. Schreiber, A. Altman, and D. H. Katz. 1983. Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc. Natl. Acad. Sci. USA 80: 3782-3786.
9. Pace, J. L., S. W. Russell, B. A. Torres, H. M. Johnson, and P. W. Gray. 1983. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130: 2011-2013.
10. Saha, B., S. Jyothi Prasanna, B. Chandrasekar, and D. Nandi. 2010. Gene modulation and immunoregulatory roles of interferon γ. Cytokine 50: 1-14.
11. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194: 1123-1140.
12. Lugo-Villarino, G., C. Vérollet, I. Maridonneau-Parini, and O. Neyrolles. 2011. Macrophage polarization: convergence point targeted by Mycobacterium tuberculosis and HIV. Front. Immunol. 2: 43.
13. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
14. Martinez, F. O. 2011. Regulators of macrophage activation. Eur. J. Immunol. 41: 1531-1534.
15. Karupiah, G., N. H. Hunt, N. J. King, and G. Chaudhri. 2000. NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev. Immunogenet. 2: 387-415.
16. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243-5248.
17. Flynn, J. L., J. Chan, and P. L. Lin. 2011. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol. 4: 271-278.
18. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. J. Exp. Med. 192: 347-358.
19. Baek, Y. S., S. Haas, H. Hackstein, G. Bein, M. Hernandez-Santana, H. Lehrach, S. Sauer, and H. Seitz. 2009. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol. 10: 18.
20. Fujihara, M., M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda. 2003. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100: 171-194.
21. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
22. Liu, J., X. Guan, T. Tamura, K. Ozato, and X. Ma. 2004. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279: 55609-55617.
23. Liu, J., X. Guan, and X. Ma. 2005. Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon gamma-induced RANTES/CCl5 expression in macrophages. J. Biol. Chem. 280: 24347-24355.
24. Schwegmann, A., R. Guler, A. J. Cutler, B. Arendse, W. G. Horsnell, A. Flemming, A. H. Kottmann, G. Ryan, W. Hide, M. Leitges, et al. 2007. Protein kinase C δ is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 104: 16251-16256.
25. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407-2412.
26. Dorsey, M. J., H. J. Tae, K. G. Sollenberger, N. T. Mascarenhas, L. M. Johansen, and E. J. Taparowsky. 1995. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 11: 2255-2265.
27. Wagner, E. F., and R. Eferl. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208: 126-140.
28. Williams, K. L., I. Nanda, G. E. Lyons, C. T. Kuo, M. Schmid, J. M. Leiden, M. H. Kaplan, and E. J. Taparowsky. 2001. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur. J. Immunol. 31: 1620-1627.
29. Williams, K. L., A. J. Zullo, M. H. Kaplan, R. R. Brutkiewicz, C. D. Deppmann, C. Vinson, and E. J. Taparowsky. 2003. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J. Immunol. 170: 2417-2426.
30. Itoh, M., M. Kojima, S. Nagao-Sato, E. Saijo, T. Lassmann, M. Kanamori-Katayama, A. Kaiho, M. Lizio, H. Kawaji, P. Carninci, et al. 2012. Automated workflow for preparation of cDNA for cap analysis of gene expression on a single molecule sequencer. PLoS ONE 7: e30809.
31. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163: 3920-3927.
32. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105: 497-504.
33. Underhill, D. M., A. Ozinsky, K. D. Smith, and A. Aderem. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96: 14459-14463.
34. Kwon, A. T., D. J. Arenillas, R. Worsley Hunt, and W. W. Wasserman. 2012. oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3 (Bethesda) 2: 987-1002.
35. Murphy, T. L., R. Tussiwand, and K. M. Murphy. 2013. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 13: 499-509.
36. Tussiwand, R., W. L. Lee, T. L. Murphy, M. Mashayekhi, W. Kc, J. C. Albring, A. T. Satpathy, J. A. Rotondo, B. T. Edelson, N. M. Kretzer, et al. 2012. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490: 502-507.
37. Glasmacher, E., S. Agrawal, A. B. Chang, T. L. Murphy, W. Zeng, B. Vander Lugt, A. A. Khan, M. Ciofani, C. J. Spooner, S. Rutz, et al. 2012. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338: 975-980.
38. Ciofani, M., A. Madar, C. Galan, M. Sellars, K. Mace, F. Pauli, A. Agarwal, W. Huang, C. N. Parkurst, M. Muratet, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
39. Betz, B. C., K. L. Jordan-Williams, C. Wang, S. G. Kang, J. Liao, M. R. Logan, C. H. Kim, and E. J. Taparowsky. 2010. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 207: 933-942.
40. Ise, W., M. Kohyama, B. U. Schraml, T. Zhang, B. Schwer, U. Basu, F. W. Alt, J. Tang, E. M. Oltz, T. L. Murphy, and K. M. Murphy. 2011. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 12: 536-543.
41. H17 differentiation. Nature 460: 405-409.
42. Ellyard, J. I., and C. G. Vinuesa. 2011. A BATF-ling connection between B cells and follicular helper T cells. Nat. Immunol. 12: 519-520.
43. Kuroda, S., M. Yamazaki, M. Abe, K. Sakimura, H. Takayanagi, and Y. Iwai. 2011. Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression. Proc. Natl. Acad. Sci. USA 108: 14885-14889.
44. Wang, C., S. Thangamani, M. Kim, B. H. Gu, J. H. Lee, E. J. Taparowsky, and C. H. Kim. 2013. BATF is required for normal expression of gut-homing receptors by T helper cells in response to retinoic acid. J. Exp. Med. 210: 475-489.
45. Li, P., R. Spolski, W. Liao, L. Wang, T. L. Murphy, K. M. Murphy, and W. J. Leonard. 2012. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490: 543-546.
46. Bast, A., K. Fischer, S. F. Erttmann, and R. Walther. 2010. Induction of peroxiredoxin I gene expression by LPS involves the Src/PI3K/JNK signalling pathway. Biochim. Biophys. Acta 1799: 402-410.
47. Kile, B. T., and W. S. Alexander. 2001. The suppressors of cytokine signalling (SOCS). Cell. Mol. Life Sci. 58: 1627-1635.
48. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23: 96-101.
49. Cooper, A. M., J. E. Pearl, J. V. Brooks, S. Ehlers, and I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68: 6879-6882.
50. Sugawara, I., H. Yamada, and S. Mizuno. 2004. STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection. Tohoku J. Exp. Med. 202: 41-50.
51. Yamada, H., S. Mizuno, and I. Sugawara. 2002. Interferon regulatory factor 1 in mycobacterial infection. Microbiol. Immunol. 46: 751-760.
52. Algood, H. M., and J. L. Flynn. 2004. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173: 3287-3296.
53. Chakravarty, S. D., J. Xu, B. Lu, C. Gerard, J. Flynn, and J. Chan. 2007. The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice. J. Immunol. 178: 1723-1735.
54. + T cell contraction and memory generation following infection. J. Exp. Med. 208: 1621-1634.
55. Singh, V., S. Jamwal, R. Jain, P. Verma, R. Gokhale, and K. V. Rao. 2012. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 12: 669-681.